This report provides comprehensive information on the current therapeutic developmental pipeline of Lixte Biotechnology Holdings, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Get Detail Report With TOC @ http://www.researchmoz.us/lixte-biotechnology-holdings-inc-product-pipeline-review-2014-report.html The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

1. Lixte Biotechnology Holdings, Inc. - Product Pipeline Review - 2014
Lixte Biotechnology Holdings, Inc. - Product Pipeline Review - 2014
Summary
Global Markets Directs, Lixte Biotechnology Holdings, Inc. - Product Pipeline Review - 2014, provides an overview of the Lixte Biotechnology Holdings, Inc.s
pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Lixte Biotechnology Holdings, Inc.s, complete with
comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It
also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides brief overview of Lixte Biotechnology Holdings, Inc. including business description, key information and facts, and its locations and
subsidiaries
- The report reviews current pipeline of Lixte Biotechnology Holdings, Inc.s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major
milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Lixte Biotechnology Holdings, Inc.s pipeline products
Reasons to buy
- Evaluate Lixte Biotechnology Holdings, Inc.s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Lixte Biotechnology Holdings, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Lixte Biotechnology Holdings, Inc.s R&D portfolio and develop key strategic initiatives to reinforce
pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Lixte Biotechnology Holdings, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Lixte Biotechnology Holdings, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand
business potential and scope
- Explore the dormant and discontinued projects of Lixte Biotechnology Holdings, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table Of Contents
table Of Contents 2
list Of Tables 4
list Of Figures 4
lixte Biotechnology Holdings, Inc. Snapshot 5
lixte Biotechnology Holdings, Inc. Overview 5
key Information 5
key Facts 5
lixte Biotechnology Holdings, Inc. - Research And Development Overview 6
key Therapeutic Areas 6
lixte Biotechnology Holdings, Inc. - Pipeline Review 9
pipeline Products By Stage Of Development 9
pipeline Products - Monotherapy 10
lixte Biotechnology Holdings, Inc. - Pipeline Products Glance 11
Lixte Biotechnology Holdings, Inc. - Product Pipeline Review - 2014

2. lixte Biotechnology Holdings, Inc. - Clinical Stage Pipeline Products 11
phase I Products/combination Treatment Modalities 11
lixte Biotechnology Holdings, Inc. - Early Stage Pipeline Products 12
preclinical Products/combination Treatment Modalities 12
lixte Biotechnology Holdings, Inc. - Drug Profiles 13
lb-100 13
product Description 13
mechanism Of Action 13
r&d Progress 13
lb-201 15
product Description 15
mechanism Of Action 15
r&d Progress 15
lb-205 16
product Description 16
mechanism Of Action 16
r&d Progress 16
lb-300 Series 17
product Description 17
mechanism Of Action 17
r&d Progress 17
lb-400 Series 18
product Description 18
mechanism Of Action 18
r&d Progress 18
lixte Biotechnology Holdings, Inc. - Pipeline Analysis 19
lixte Biotechnology Holdings, Inc. - Pipeline Products By Target 19
lixte Biotechnology Holdings, Inc. - Pipeline Products By Route Of Administration 20
lixte Biotechnology Holdings, Inc. - Pipeline Products By Molecule Type 21
lixte Biotechnology Holdings, Inc. - Pipeline Products By Mechanism Of Action 22
lixte Biotechnology Holdings, Inc. - Recent Pipeline Updates 23
lixte Biotechnology Holdings, Inc. - Dormant Projects 25
lixte Biotechnology Holdings, Inc. - Company Statement 26
lixte Biotechnology Holdings, Inc. - Locations And Subsidiaries 30
head Office 30
appendix 31
methodology 31
coverage 31
secondary Research 31
primary Research 31
expert Panel Validation 31
contact Us 32
disclaimer 32
list Of Tables
lixte Biotechnology Holdings, Inc., Key Information 5
lixte Biotechnology Holdings, Inc., Key Facts 5
lixte Biotechnology Holdings, Inc. - Pipeline By Indication, 2014 8
lixte Biotechnology Holdings, Inc. - Pipeline By Stage Of Development, 2014 9
lixte Biotechnology Holdings, Inc. - Monotherapy Products In Pipeline, 2014 10
lixte Biotechnology Holdings, Inc. - Phase I, 2014 11
lixte Biotechnology Holdings, Inc. - Preclinical, 2014 12
lixte Biotechnology Holdings, Inc. - Pipeline By Target, 2014 19
lixte Biotechnology Holdings, Inc. - Pipeline By Route Of Administration, 2014 20
lixte Biotechnology Holdings, Inc. - Pipeline By Molecule Type, 2014 21
lixte Biotechnology Holdings, Inc. - Pipeline Products By Mechanism Of Action, 2014 22
lixte Biotechnology Holdings, Inc. - Recent Pipeline Updates, 2014 23
lixte Biotechnology Holdings, Inc. - Dormant Developmental Projects,2014 25
list Of Figures
lixte Biotechnology Holdings, Inc. - Pipeline By Top 10 Indication, 2014 7
lixte Biotechnology Holdings, Inc. - Pipeline By Stage Of Development, 2014 9
lixte Biotechnology Holdings, Inc. - Monotherapy Products In Pipeline, 2014 10
lixte Biotechnology Holdings, Inc. - Pipeline By Top 10 Target, 2014 19
lixte Biotechnology Holdings, Inc. - Pipeline By Top 10 Route Of Administration, 2014 20
lixte Biotechnology Holdings, Inc. - Pipeline By Top 10 Molecule Type, 2014 21
lixte Biotechnology Holdings, Inc. - Pipeline Products By Top 10 Mechanism Of Action, 2014 22
Lixte Biotechnology Holdings, Inc. - Product Pipeline Review - 2014

3. ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Lixte Biotechnology Holdings, Inc. - Product Pipeline Review - 2014